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Abstract Hyposplenic patients are at risk of overwhelming
post-splenectomy infection (OPSI), which carries mortality
of up to 70%. Therefore, preventive measures are warranted.
However, patients with diminished splenic function are
difficult to identify. In this review we discuss immunological,
haematological and scintigraphic parameters that can be used
to measure splenic function. IgM memory B cells are a
potential parameter for assessing splenic function; however,
more studies are necessary for its validation. Detection
of Howell–Jolly bodies does not reflect splenic function
accurately, whereas determining the percentage of pitted
erythrocytes is a well-evaluated method and seems a good
first-line investigation for assessing splenic function. When
assessing spleen function,
99mTc-labelled, heat-altered, autol-
ogous erythrocyte scintigraphy with multimodality single
photon emission computed tomography (SPECT)-CT tech-
nology is the best approach, as all facets of splenic function
are evaluated. In conclusion, although scintigraphic methods
are most reliable, they are not suitable for screening large
populations. We therefore recommend using the percentage
of pitted erythrocytes, albeit suboptimal, as a first-line
investigation and subsequently confirming abnormal read-
ings by means of scintigraphy. More studies evaluating the
value of potentially new markers are needed.
Introduction
The spleen is the largest lymphoid organ in the human
body. Its rich and diverse population of immune cells and
its ingenious anatomy that enables optimal surveillance
and phagocytosis of circulating blood elements play an
important role in the defence against pathogens. Table 1
summarizes the different aspects of splenic functions.
After splenectomy, patients are at increased risk of
overwhelming post-splenectomy infection (OPSI; see
Table 2 [1–4].
Apart from patients with a status after splenectomy,
there is a much larger group of patients with diminished
splenic function. Many diseases are associated with a
dysfunctional spleen (Table 3)a n dt h ed e g r e eo fs p l e n i c
dysfunction varies between patients [13]. For patients
suspected to have a spleen with diminished function, it is
important to quantify their splenic function in order to
assess the risk of developing OPSI. Subsequently, preven-
tive measurements can be taken and, in the case of
infection, therapy can be started without delay. In this
review we evaluate the methods available to measure
splenic function.
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Throughout the years, several methods have been devel-
oped to quantify the many different functions of the spleen.
These methods are based on haematological, immunolog-
ical and scintigraphic parameters.
Haematological parameters
Haematological methods reflect the capacity of the spleen
to phagocytose deviant erythrocytes and to facilitate an
environment wherein erythrocytes rid themselves of solid
waste material [14, 15]. In the event of splenic dysfunction
Table 2 Overwhelming post-splenectomy infection
Factor Description
Background After splenectomy, patients are at risk of overwhelming infection. This syndrome is called overwhelming
post-splenectomy infection (OPSI) or post-splenectomy sepsis (PSS). Patients with functional asplenia are also at risk
of this syndrome.
Symptoms OPSI is characterised by a mild onset with flu-like symptoms such as low-grade fever, chills, muscle aches and
nausea. However, a subsequent fast deterioration may occur in hours rather than days, leading to fulminant sepsis,
disseminated intravascular coagulation and multi-organ failure [5].
Incidence The incidence of OPSI is estimated to be low, 2–5 per 1,000 asplenic patients per year [6]. The lifetime risk of
developing OPSI is estimated to be 5% [7]. Although more than half of these infections occur within the first 2 years
after splenectomy, the risk remains increased lifelong [1, 8].
Mortality Although the incidence is low, mortality is high. Numbers in the literature vary between 50 and 70% [1, 3]. Notably,
68% of patients die in the first 24 h, and 80% within 48 h of onset [3, 9].
Micro-organisms Encapsulated bacteria are important causative organisms of OPSI. S. pneumoniae causes 70% of bacteraemic episodes
after splenectomy [3]. Other pathogens responsible for OPSI are H. influenzae, N. meningitidis, E. coli and
Pseudomonas.
Guideline To prevent OPSI several preventive measures should be taken, such as immunisation against the encapsulated bacteria
S. pneumoniae, H. influenzae B and N. meningitidis C. Furthermore, patients should use continuous prophylactic
antibiotics during the first 2 years after splenectomy and have on-demand antibiotics to use in case of (suspected)
infection [10–12].
Red pulp
Extramedullary haematopoiesis if necessary
Facilitating an environment wherein erythrocytes rid themselves of solid waste material
Blood filter for foreign material and damaged and senescent blood cells
Storage site for iron, erythrocytes, platelets, plasmablasts and plasma cells
Rapid release of antigen-specific antibodies into the circulation produced by red pulp plasma cells
Defence against bacteria using the iron metabolism of its macrophages
White pulp
T cell zone (periarterial lymphatic sheath) and B cell zone (follicles)
Storage site for B and T lymphocytes
Development of B and T lymphocytes upon antigenic challenge
Release of immunoglobulins upon antigenic challenge by B lymphocytes
Production of immune mediators involved in clearance of bacteria such as complement, opsonins,
properdin and tuftsin
Marginal zone
Phagocytosis of circulating microorganisms and immune complexes by MZ macrophages
Development of marginal zone B lymphocytes upon TI-2 antigenic challenge
Blood trafficking of B and T lymphocytes
Release of immunoglobulins upon antigenic challenge by splenic B lymhocytes
Table 1 Functions of the spleen
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in abnormal circulating red blood cells. Furthermore,
large amounts of thrombocytes and leukocytes normally
reside in the spleen. Circulating thrombocyte- and
leukocyte counts can either be increased or decreased,
indicative of hyposplenism in a patient with a dysfunc-
tional spleen (for example, thrombocytosis in asplenia
and thrombopaenia associated with splenomegaly) [13,
16].
One of the first methods available to evaluate splenic
function was the detection of erythrocytes containing
Howell–Jolly bodies, using a light microscope viewing a
stained peripheral blood smear [17, 18]. Howell–Jolly
bodies are basophilic DNA remains from the nucleus of
the erythrocyte precursor cell. Normally, upon leaving the
bone marrow, the erythrocyte precursor cell expels its
nucleus. In some erythrocytes, however, a small portion of
DNA remains. Normally, the spleen clears the erythrocyte
of these nuclear remnants or removes the erythrocytes from
the circulation, but when the spleen is absent or has a
decreased function, these Howell–Jolly body-containing
erythrocytes remain in the circulation. A recently developed
method uses flow cytometry to quantify the amount of
erythrocytes containing Howell–Jolly bodies [19].
Table 3 Causes of hyposplenism (adapted from William and Corazza,
Table 1 [13])
Category Condition
Congenital disorders Congenital asplenia (isolated)
Ivemark’s syndrome
Stormorken’s syndrome
Autoimmune polyendocrinopathy-
candidiasis-ectodermal dystrophy
(APECED) syndrome
Fetal hydantoin syndrome
Congenital cyanotic heart disease
Normal and premature neonates
Sickle haemoglobinopathies SS
SC
S/B thalassemia
SE
SO Arab
SD Los Angeles
Gastrointestinal diseases Coeliac disease
Ulcerative colitis
Crohn’s disease
Dermatitis herpetiformis
Tropical sprue
Whipple’s disease
Idiopathic ulcerative enteritis
Intestinal lymphangiectasis
Hepatic disorders Alcoholic liver disease
Chronic active hepatitis
Liver cirrhosis and portal hypertension
Primary biliary cirrhosis
Autoimmune disorders Systemic lupus erythematosis
Discoid lupus
Antiphospholipid syndrome
Vasculitis
Rheumatoid arthritis
Glomerulonephritis
Sjögren’s syndrome
Mixed connective tissue disease
Graves’ disease
Hashimoto’s thyreoiditis
Multiple sclerosis
Haematological/neoplastic
disorders
Bone marrow transplantation
Graft versus host disease
Acute leukaemias
Chronic lymphocytic leukaemia
Non-Hodgkin’s lymphoma
Essential thrombocythaemia
Systemic mastocytosis
Sézary syndrome
Pure red cell asplenia
Fanconi syndrome
Table 3 (continued)
Category Condition
Advanced breast cancer
Haemangiosarcoma of the spleen
Haemangioendothelioma of the spleen
Malignant histiocytosis
Sepsis/infectious diseases Disseminated meningeococcaemia
Acquired immunodeficiency syndrome
Circulatory disorders Splenic artery thrombosis
Splenic vein thrombosis
Coeliac artery thrombosis
Miscellaneous Old age
Alcoholism
Sarcoidosis
Amyloidosis
Methyldopa administration
Hypopituitarism
Selective IgA deficiency
Primary pulmonary hypertension
Splenic irradiation
Thorotrast exposure
Total parenteral nutrition
? High-dose corticosteroids
Surgical splenectomy
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smears of patients with absent or diminished splenic
function are acanthocytes (spur cells), target cells (codo-
cytes: erythrocytes with a pattern of central staining, a ring
of pallor and an outer ring of staining), haemoglobin
remnants (Heinz bodies), siderocytes and iron granulocytes
(Pappenheimer bodies) [13, 16].
In individuals with a dysfunctional or absent spleen the
membrane of erythrocytes appears to contain so called
“pits” when studied with interference phase microscopy
[20]. With electron microscopy it was shown that these
“pits” are in fact large vacuoles (about 300 nm in diameter)
beneath or attached to the plasma membrane. These
vacuoles have low optical density, because of waste
material contained in the erythrocyte, such as ferritine,
haemoglobin and rest material of mitochondria and mem-
branes [14, 15, 21]. In case of normal splenic function, pits
are seen in 0–4% of the erythrocytes [20, 22, 23]. A pit
count above 4% has been associated with hyposplenism,
although asplenia or clinically relevant hyposplenism is
most often associated with much higher values, ranging
from 15 to 70% [22, 24, 25]. Casper et al. noted that in 5
patients with sickle cell disease who developed sepsis and/
or meningitis, pit counts were higher than 15% and
therefore the authors suggested this as a cut-off value for
significant splenic dysfunction [23]. The same cut-off value
was suggested by Corazza et al., who noted that patients
who underwent splenectomy had functional residual splenic
tissue when pits counts were beneath 16% [26].
Another method of evaluating spleen function is count-
ing erythrocytes containing argyrophilic inclusions, where
normal values range from 0 to 3%. This method uses a
silver stain and in comparison with a normal Wrights stain,
the argyrophilic inclusions are shown to be Howell–Jolly
bodies, Pappenheimer bodies and other inclusions visible in
patients with a decreased or absent splenic function [27].
Immunological parameters
The spleen contains a large amount of immune cells [28]. In
comparison to the peripheral blood lymphocyte compart-
ment, the spleen percentually contains more B-cells and
less CD4
+ and CD8
+ T cells. The percentage of CD8
+ T
cells is higher in the spleen, leading to an inverse CD4/CD8
ratio. Both splenic CD4
+ and CD8
+ Tcell populations show
a higher number of activated cells and splenic CD8
+ T cells
show a more differentiated cytotoxic CD27
-CD45RA
+
memory phenotype. Thus, the distribution of the different
lymphocyte subsets is markedly different between spleen
and peripheral blood, inferring an important and distinct
role for the spleen in CD4
+ and CD8
+ Tcell activation [29].
After splenectomy, some immunological functions of the
spleen can be taken over by other organs, such as the liver,
bone marrow and peripheral lymph nodes. Therefore, these
functions are not suitable as a reliable parameter for
measuring spleen function. However, the spleen plays a
specific role in the defence against encapsulated bacteria
[1–4]. This is mainly related to the marginal zone (MZ)
containing marginal zone B cells (MZ B cells) and
macrophages. Marginal zone macrophages are able to
capture whole encapsulated bacteria from the circulation
and subsequently initiate a humoral immune response
[30]. MZ B cells are a distinct B cell lineage that, unlike
other B cell lineages, develop and mutate immunoglobin
(Ig) receptors during the first years of life without being
engaged in any immune response. Upon stimulation with
thymus-independent type 2 (TI-2) antigens expressed by
encapsulated bacteria, the prediversified MZ B cells can
rapidly proliferate and differentiate into antigen-presenting
cells or into IgM-, IgG-, and IgA-secreting plasma cells,
circulating for several months. MZ B cells do not
differentiate into memory cells and are therefore part of
the (immediate) innate immunity against invading pathogens
[31–33].
Marginal zone B cells do not only reside in the MZ, but
are also present in the circulation and in other lymphoid
tissue [34–36]. The spleen is, however, essential for the
maintenance of the MZ B cell population, as appears from a
decrease in MZ B cell counts after splenectomy. In contrast
to one report [31], other studies have shown that young
patients with congenital asplenia have a normal blood MZ
B cell population, whereas this circulating MZ B cell subset
fails to expand in older asplenic individuals [32, 37].
Therefore, the amount of circulating MZ B cells may be an
indication of immunological function of the spleen. The
effect of diminished spleen function on the composition of
naïve, memory and effector (antigen-specific) T cells in the
circulation is not yet known. Decreased numbers of
circulating memory B cells have been described in patients
with diminished splenic function [31, 32, 37], although this
might be due to a decrease only in IgM memory B cells
rather than in other B memory cells [31, 37].
Some studies have described tuftsin as a potential marker
for immunological spleen function, since production of this
peptide is mainly dependent on the spleen [38, 39]. Tuftsin
is a tetrapeptide with protective bactericidal characteristics,
as it has been shown to stimulate phagocytosis by
neutrophils and macrophages [40]. Decreased serum levels
of tuftsin are seen in splenectomised patients [38, 39] and in
patients suffering from sickle cell disease [41] and coeliac
disease [42].
Scintigraphic parameters
Like haematological parameters, scintigraphic parameters
use the capacity of the spleen to filter the blood of deviant
1468 Eur J Clin Microbiol Infect Dis (2010) 29:1465–1473cells and particles to measure its activity. The radiophar-
maceutical most commonly used for this purpose is
technetium-99m (
99mTc)-labelled, heat-altered, autologous
erythrocytes, which have replaced the previously common-
ly used
99mTc-labelled sulphur colloids [43–48].
99mTc-
labelled sulphur colloid scintigraphy has been used for
visualisation of the phagocytic function of the liver and
spleen and was once a common study for evaluating for the
presence or absence of neoplastic disease, cirrhosis or
portal hypertension, being largely supplanted by other
modalities like ultrasonography, (PET)-CT or MRI to date
[49]. For the assessment of spleen function or the presence
of an accessory spleen,
99mTc-labelled, heat-altered, autol-
ogous erythrocyte scintigraphy is now recommended,
because, in contrast to sulphur colloid scintigraphy,
sensitivity is not hampered by the relatively high liver
uptake [43–48, 50]. Sulphur colloids are captured by
phagocytosis, whereas autologous, heat-altered erythro-
cytes are sequestrated by the normal spleen [50, 51].
The normal spleen accumulates about 90% of injected
autologous, heat-altered erythrocytes, in contract to 10%
of injected sulphur colloids, which are mainly phagocy-
tosed by the liver [50]. After intravenous re-injection of
these cells, splenic function can be determined by:
1. Measuring the clearance rate of the injected cells from
the circulation by analysing blood samples using a
gamma well-counter
2. Determining the splenic uptake either solely or by
determining the spleen-to-liver uptake ratio using a
gamma probe or camera
Besides quantitative information on splenic function,
planar or dynamic scintigraphy enables visualisation of
organ function. In addition to planar scintigraphy, modern
multimodality single photon emission computed tomogra-
phy (SPECT)-CT gamma cameras enable assessment of
both function and anatomy (organ volume and structure)
within a single investigation, potentially introducing clini-
cally useful parameters like organ-specific functional
volumes [52].
Alternatively, unaltered autologous or donor erythrocytes
or platelets can be radio-labelled for assessment of patholog-
ical sequestration in the spleen in patients with low peripheral
cell counts, such as in idiopathic thrombocytopaenic purpura
or auto-immune anaemia [43, 50, 53–55]
Different approaches compared
As there are many approaches to assessing splenic function,
the question arises as to which method is most reliable and
which is best for clinical use. Knowledge about correlation
and functionality of the different available methods is
required before a deliberate decision on which method to
use can be made. In the next few paragraphs we give an
overview of studies comparing the haematological, immu-
nological and scintigraphic parameters in the measurement
of splenic function.
Scintigraphic parameters compared
Although
99mTc-labelled, heat-altered, autologous erythro-
cytes as well as
99mTc-labelled sulphur colloids have been
used in studies on splenic function, not much recent data
can be found on their correlation when determining the
amount of functional splenic tissue. When computing
splenic volumes based on planar scintigraphy in two groups
of coeliac patients, splenic volumes derived from
99mTc-
labelled sulphur colloid scintigraphy correlated well with
those from
99mTc-labelled, heat-altered erythrocyte scintig-
raphy [56]. Furthermore, there was a good correlation
between volume of functional splenic tissue and splenic
function measured using
99mTc-labelled heat-altered erythro-
cyte clearance rates from the circulation. Another publication
by Smart et al. in patients with mainly inflammatory bowel
disease (IBD) showed a strong correlation between clearance
of the cells from the circulation and functional spleen
volume, with a large variation around the regression line,
leading to the conclusion that functional spleen size
determination was not able to replace measurement of the
rate of heat-altered erythrocyte clearance from the circulation
in the assessment of hyposplenism [57]. However, these
studies were performed in the pre-tomographic and ultraso-
nographic era using planar imaging for volume calculation,
making it less reliable. Furthermore, only functioning spleen
was visualised and eligible for volume calculation, implying
a direct correlation between function and size [57, 58]
A more recent study by Gotthardt et al. showed that
spleen–liver ratios as soon as 10 min after reinjection of
99mTc-labelled, heat-altered erythrocytes reliably predict
spleen function in IBD patients when compared to the rate
of clearance of the cells from the circulation. The spleen–
liver ratio measured with
99mTc-labelled sulphur colloids
showed no correlation with the clearance of the
99mTc-
labelled, heat-altered erythrocytes [59].
Scintigraphic and haematological parameters compared
The correlation between haematological parameters and
scintigraphic parameters has been studied more accurately.
In patients with sickle cell disease (SCD), a correlation was
found between the uptake of
99mTc-labelled sulphur colloid
by functional splenic tissue and the percentage of pitted
erythrocytes [23–25]. In a study by Pearson et al. amongst
64 children with homozygous SCD between 8 and
13 months of age, it was found that sensitivity, specificity
Eur J Clin Microbiol Infect Dis (2010) 29:1465–1473 1469and predictive values were all between 90% and 98% when
correlating uptake with a percentage of pitted erythrocytes
of less than 3.5% [24]. Another study by Lane et al.
described patients with heterozygous SCD (HbSC), where
it was demonstrated that pit counts of more than 20% were
indicative of functional asplenia, whereas pit counts lower
than 20% were associated with normal or near normal
splenic function [25]. Furthermore, in a study of patients
with coeliac disease and dermatitis herpetiformis, a corre-
lation was found between the percentage of pitted eryth-
rocytes and the size of functioning splenic tissue, as
measured by using
99mTc-labelled, autologous, heat-
altered erythrocytes rather than sulphur colloids [22]. In
this same group of patients, a significant correlation was
found between the percentage of pitted erythrocytes and the
clearance rate of
99mTc-labelled, heat-altered erythrocytes.
However, another study describing patients with megalo-
blastic anaemia and iron-deficient anaemia, which are rare
causes of hyposplenia, no correlation was found between
the percentages of pitted erythrocytes and the blood
clearance rate, splenic uptake values and splenic volumes
[60]. An explanation for these results could not be given by
the authors; however, they state that erythrocyte pits may be
heterogeneous in origin, composition, or removal kinetics
and may be different in individuals who are hyposplenic for
various reasons.
The presence of the Howell–Jolly bodies has historically
been associated with diminished splenic function. However,
Howell–Jolly bodies have been shown not to correlate with
blood clearance of the
99mTc-labelled, heat-altered erythro-
cytes [58, 59]. Similar results were obtained using
51chromi-
um-labelled heat-altered erythrocytes [61]. The presence of
Howell–Jolly bodies did also not correlate with the spleen–
liver activity ratio measured with either
99mTc-labelled, heat-
altered erythrocytes or
99mTc-labelled sulphur colloids [59].
Haematological parameters compared
Although there is discussion in the literature, it was found
that the percentage of erythrocytes containing Howell–Jolly
bodies correlated with the percentage of pitted erythrocytes
[23, 62]. This correlation, however, was only present at pit
counts higher than 8% and when at least 10,000 erythrocytes
were examined. Mild cases of hyposplenism could not be
detected by determining percentages of erythrocytes with
Howell–Jolly bodies, since a pit count above 4% is indicative
of hyposplenism. No note was made of what percentage
of erythrocytes containing Howell–Jolly bodies indicates
hyposplenism [62].
The argyrophilic inclusion-positive erythrocyte count
has sensitivity of 88.9% and specificity of 97.1% for
splenic dysfunction when using the percentage of pitted
erythrocytes as a gold standard [27].
Immunological and haematological parameters compared
Because the amount of circulating IgM memory B cells was
first described in 2005 as a method of quantifying splenic
hypofunction, research on this subject is still limited. Two
studies describe a correlation between the amount of
circulating IgM memory B cells and the percentage of
pitted erythrocytes in treated patients with coeliac disease
and IBD [37, 63]. In one study, patients with IBD were
divided into either having a decreased splenic function
(>4% pitted erythrocytes) or having a normal splenic
function (<4% pitted erythrocytes) and both were compared
with a control group [37]. Patients with decreased splenic
function were shown to have lower amounts of circulating
memory B cells, mainly IgM memory B cells, compared
with healthy controls as well as individuals classified as
having normal splenic function. Furthermore, IgM memory
B cells were shown to be completely absent in the
peripheral blood of splenectomised patients. As described
above, serum tuftsin might be indicative of splenic
function, although not much research on the subject has
been published. This potential marker was studied in 52
untreated patients with coeliac disease [42]. In accordance
with the study on IgM memory B cells, patients were
divided into groups based on pit count. It was found that
hyposplenic as well as eusplenic coeliac patients had
significantly lower tuftsin activity than healthy controls,
but significantly higher than splenectomised patients. There
was less tuftsin activity in hyposplenic patients than in
eusplenic patients. Furthermore, a correlation was found
between serum tuftsin activity and the percentage of pitted
erythrocytes.
Discussion
Knowledge about splenic function is important, since
patients with an absent spleen or decreased splenic function
are at risk of developing severe infections with a high
mortality rate. Quantification of spleen function could
become an important tool for physicians in their decision-
making regarding the need for preventive measures.
However, when assessing splenic function in a clinical
setting, physicians should be aware of the multiple facets of
spleenfunction(asdescribedinTable1) and thus the different
possible approaches to determining splenic function.
In many diseases associated with splenic hypofunction
such as sickle cell disease, coeliac disease, IBD and
systemic lupus erythematosis, splenic function changes as
the underlying disease activity alters [56, 57, 61, 64–67]. It
has been suggested that these changes in splenic function
are due to two components of splenic hypofunction in
active disease: first, impaired splenic function, which may
1470 Eur J Clin Microbiol Infect Dis (2010) 29:1465–1473deteriorate during high disease activity, but may improve
with treatment, and second, splenic atrophy, which may
lead to irreversible loss of volume and therefore also
irreversible loss of function. Illustrating this phenomenon,
two patients are described in whom the size of the
functional splenic tissue did not alter during relapse of the
disease, causing the hyposplenia, while the clearance rate of
heat-damaged autologous erythrocytes was prolonged
[56, 57]. Shifts in the splenic volume-function relation can
also occur in other situations, such as splenomegaly which
is frequently observed in hyposplenic heterozygote sickle-
cell patients [68]. Also, hypersplenism with homogeneous
organ function, splenic infarction, splenomas (regenerating
nodules) [69] or transition to autosplenectomy can shift the
splenic volume–function relation [70].
Because functional splenic tissue can be temporarily
impaired during increased disease activity, whereas splenic
atrophy is permanent, it is important to be informed about
function as well as the actual volume of the organ. To
measure the activity of the functional compartment of the
spleen,
99mTc-labelled heat-altered autologous erythrocyte
scintigraphy with quantification of spleen uptake seems the
most appropriate technique. This method is well evaluated,
especially in comparison with other methods [59]. Clear-
ance rates of
99mTc-labelled, heat-altered, autologous
erythrocytes from the circulation should be considered
carefully, since this is not solely dependent on splenic
sequestration as the liver also partially participates in this
process. Although liver uptake of
99mTc-labelled, heat-
altered erythrocytes is low in controls, absolute liver uptake
can vary considerably, potentially affecting secondary
parameters like the spleen–liver ratio [52]. Consequently,
as the spleen is not the unique sequestering organ, with
variability of liver uptake that possibly increases when
splenic function is diminishing, this phenomenon may
affect the axiom that measured blood clearance of cells
reflects pure spleen function. Therefore, assessment of pure
splenic uptake in function of the administered dose might
be a better strategy.
Performing
99mTc-labelled, heat-altered erythrocyte scin-
tigraphy on state-of-the-art SPECT-CT gamma cameras will
enable the combination of both function and anatomy
(volume) within a single investigation with the possibility
of accounting for the exact organ volume and the volume of
functional organ tissue within the organ.
The large amount of potential hyposplenic patients
(Table 3) makes it almost impossible to evaluate splenic
function by means of scintigraphy in every patient.
Laborious preparation (cell isolation, denaturation and
labelling), gamma (SPECT/CT) camera availability and
even the radiation burden—albeit low—requires selection
of patients eligible for this advanced technique. To screen a
large group of potential hyposplenic patients, a more
economical, simple and easily accessible method without
radiation burden is needed. An alternative is counting the
percentageof pitted erythrocytes, which is alsowellevaluated
[22–25, 60]. It is quick, cheap and non-invasive. However,
interference phase microscopy needs to be available as well
as trained personnel. It should also be considered that
erythrocyte pits may be heterogeneous with regard to their
origin, composition, or removal kinetics [60]. Percentages
indicating hyposplenism may therefore be different in
individuals who are hyposplenic for various reasons.
Detection of Howell–Jolly bodies does not seem to be a
reliable method of evaluating splenic function, as correlation
with other methods is poor [59]. However, measuring the
percentage of Howell–Jolly bodies via flow cytometry is a
potentially more reliable parameter as large amounts of
erythrocytes can be screened [19]. The percentage of
argyrophilic inclusion-positive erythrocytes is a parameter
that is simple and seems reliable [27]. Measuring the
percentages of both Howell–Jolly bodies by flow cytometry
as well as argyrophilic inclusion-positive erythrocytes does
not require special equipment. However, both methods
require extensive validation. More studies evaluating the
value of potentially new (immunological) markers are
needed. Measuring the amount of IgM memory B cells
seems a promising method, giving the opportunity to
measure the susceptibility to infection in a more direct way
[31, 37, 63]. Until these new methods have been validated,
quantification of the percentages of pitted erythrocytes seems
most reliable to screen for potential hyposplenic patients.
Abnormal readings can subsequently be confirmed by
scintigraphy.
Conclusion and recommendations
Large studies comparing all available methods in various
patient populations with splenic hypofunction are lacking,
and data on sensitivity and specificity are scarce. To
measure splenic function accurately it is important to have
knowledge about the volume and function of the active
splenic tissue as well as the volume of the organ itself.
Function in splenic tissue can temporarily be decreased
because of increased disease activity, while the spleen
might actually still be partially functioning and is not in
state of atrophy. Assessment of spleen function using
99mTc-labelled, heat-altered, autologous erythrocyte scintig-
raphy combined with a multimodality SPECT-CT approach
seems best for this purpose as all facets of splenic function
are evaluated. Measuring the clearance rates of
99m
Tc-labelled, heat-altered, autologous erythrocytes from the
circulation should be considered carefully as a method of
assessing splenic function, since this is not solely depen-
dent on spleen activity.
Eur J Clin Microbiol Infect Dis (2010) 29:1465–1473 1471The population of hyposplenic patients is too large to
screen by the use of scintigraphy as a first-line investiga-
tion. Therefore, a cheaper, simpler, more accessible method
is necessary. At present, we recommend using the percent-
age of pitted erythrocytes for this purpose, and refer
patients with abnormal percentages for scintigraphy. Final-
ly, more studies evaluating the value of potentially new
(immunological) markers are needed.
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